HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of chemical blockade of PKC with Gö6976 and Gö6983 on proliferation and MAPK activity in IL-6-dependent plasmacytoma cells.

Abstract
Interleukin-6 (IL-6) mediates growth of murine B9 hybridoma/plasmacytoma cells via Ras-dependent mitogen-activated protein kinase (MAPK) pathway. Preincubation of cells with selective protein kinase C (PKC) inhibitors Gö6976 and Gö6983 leads to enhancement of IL-6-induced p44/p42 MAPK activity. The basal p44/p42 MAPK activity is also stimulated in the presence of both inhibitors. On the other hand, Gö6976 completely blocks proliferation, but Gö6983 which does not inhibit PKC(mu) has no effect on the cell growth. These findings suggest that PKC(mu) is required for proliferation and other PKC isoenzymes are involved in regulation of IL-6-dependent growth of B9 cells by negative regulation of the MAPK pathway.
AuthorsIanko Iankov, Maria Praskova, Silvia Kalenderova, Zvetanka Tencheva, Ivan Mitov, Vanio Mitev
JournalLeukemia research (Leuk Res) Vol. 26 Issue 4 Pg. 363-8 (Apr 2002) ISSN: 0145-2126 [Print] England
PMID11839379 (Publication Type: Journal Article)
Chemical References
  • Carbazoles
  • Enzyme Inhibitors
  • Indoles
  • Interleukin-6
  • Go 6976
  • Protein Kinase C
Topics
  • Carbazoles (pharmacology)
  • Depression, Chemical
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Indoles (pharmacology)
  • Interleukin-6 (metabolism)
  • MAP Kinase Signaling System (drug effects)
  • Plasmacytoma (metabolism, pathology)
  • Protein Kinase C (antagonists & inhibitors)
  • Signal Transduction (drug effects)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: